Why Evidence Generation Should Matter to Payers-Reply.
Publication
, Journal Article
Abbasi, AB; Curtis, LH; Califf, RM
Published in: JAMA
December 10, 2024
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
December 10, 2024
Volume
332
Issue
22
Start / End Page
1947 / 1948
Location
United States
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Abbasi, A. B., Curtis, L. H., & Califf, R. M. (2024). Why Evidence Generation Should Matter to Payers-Reply. JAMA, 332(22), 1947–1948. https://doi.org/10.1001/jama.2024.20647
Abbasi, Ali B., Lesley H. Curtis, and Robert M. Califf. “Why Evidence Generation Should Matter to Payers-Reply.” JAMA 332, no. 22 (December 10, 2024): 1947–48. https://doi.org/10.1001/jama.2024.20647.
Abbasi AB, Curtis LH, Califf RM. Why Evidence Generation Should Matter to Payers-Reply. JAMA. 2024 Dec 10;332(22):1947–8.
Abbasi, Ali B., et al. “Why Evidence Generation Should Matter to Payers-Reply.” JAMA, vol. 332, no. 22, Dec. 2024, pp. 1947–48. Pubmed, doi:10.1001/jama.2024.20647.
Abbasi AB, Curtis LH, Califf RM. Why Evidence Generation Should Matter to Payers-Reply. JAMA. 2024 Dec 10;332(22):1947–1948.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
December 10, 2024
Volume
332
Issue
22
Start / End Page
1947 / 1948
Location
United States
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences